Tagged Articles

colorectal cancer 20 articles

Low dose aspirin therapy may help prevent pancreatic cancer

aspirin - FDA image

A low, daily dose of aspirin has been praised for its cardiovascular benefits, but new research shows that the therapy may also ward off pancreatic cancer, one of the deadliest forms of the disease. The study, conducted by researchers at the Yale School of Public Health, claims daily low-dose aspirin therapy can lower pancreatic cancer risk by up to 48 percent. Low-dose aspirn therapy has already been credited for reducing risk of ovarian, colorectal, stomach, esophageal, prostate, breast, lung, and skin cancers. Researchers studied information on aspirin use and medical histories for 362 people with pancreatic cancer and 690 people ... Read More

Smoking-related COPD takes life of Marlboro Man

smoking

Another Marlboro Man has died from a smoking-related disease. Eric Lawson, one of several rugged-looking men paid by the tobacco company Phillip Morris to represent the company’s Marlboro cigarette brand, died of chronic obstructive pulmonary disease (COPD) on January 10. He was 72. Lawson was not only a spokesman for Marlboro, he even smoked the cigarettes – as many as three packs a day. By the 1990s, he saw the error of his ways, and spoke of the hazards of cigarette smoking in public service announcements for the American Cancer Society. Yet, even Lawson couldn’t shake the habit, and continued ... Read More

Surgeon general report: More serious, deadly diseases linked to tobacco use

smoking

Fifty years since the surgeon general warned that cigarette smoking could have deadly health consequences, resulting in a decades-long effort to place tighter restrictions on the sale and use of tobacco products, more health problems have been linked to tobacco use. Smoking can cause liver cancer, colorectal cancer, type 2 diabetes, age-related macular degeneration, erectile dysfunction and rheumatoid arthritis, according to a report by Acting Surgeon General Boris D. Lushniak. Smoking can also worsen asthma, cause cleft lips and palates in developing fetuses, and cause strokes in non-smokers exposed to second-hand smoke, the report states. And, due to changes in ... Read More

Long-term use of cholesterol-lowering statins linked to increased risk of breast cancer

lipitor

A new study suggests that women who are long-term users of cholesterol-lowering statins are at 83 to 143 percent greater risk of developing breast cancer. The report, published in the journal Cancer Epidemiology, Biomarkers & Prevention, comes just weeks after news that the highly prescribed statin Lipitor increases the risk of developing type 2 diabetes, in particular among postmenopausal women with a body mass index (BMI) of less than 25. Researchers have found that statin drugs can decrease inflammation throughout the body, in particular in the blood vessels. This has led scientists to consider whether statins can also help treat ... Read More

Colorectal cancer drug gets FDA priority review

fda-logo

An experimental cancer drug will get priority review by the Food and Drug Administration (FDA) as part of the agency’s effort to speed up the approval process for drugs considered potentially significant therapeutic advancements of existing therapies for life threatening conditions. Typically, it takes drugs 10 to 12 months to go through approval channels with drug regulators. The new expedited process cuts that time in half to about six months. Proponents say the process will help speed lifesaving drugs to the sickest patients. The agency will review Bayer’s colorectal cancer drug regorafenib under the new process. The drug is designed ... Read More

Statins may protect against breast cancer

Cholesterol-lowering drugs known as statins may help prevent breast cancer in some women, suggests a new study published in the journal Cell. The study looked at the p53 tumor suppressor gene, which stops the uncontrolled growth of cancer cells. Some women have a mutated form of this gene. When these mutant p53 cells were treated in a laboratory with statins, the cells stopped growing and in some cases these cells died. The study suggests that there may be classes of breast cancer patients who will respond better to statins than others. The study could likely lead to a clinical trial ... Read More

Too many colonoscopies performed on those at low risk for colon cancer

People considered “low risk” for colorectal cancer are having too many colonoscopies, and not enough patients considered “high risk” for the disease are having timely follow-up procedures, according to researchers with the University of Pittsburgh School of Medicine. There is no debate that colonoscopies are vital for the early detection and treatment of cancers of the colon and rectum. Colorectal cancer is the third most deadly cancer among American men and women. The American Cancer Society recommends people begin regular colon screenings at age 50 or earlier if they have a family history of the disease or are presenting bothersome ... Read More

People should be more proactive with their health

“In the emergency room, I end up diagnosing a lot of cancer,” says Dr. Mylissa Graber, medical director of the emergency department at West Palm Beach’s Good Samaritan Medical Center. “People don’t go to the doctor, don’t follow up on getting their tests done, and show up when (diseases) are pretty advanced,” she said to the Palm Beach Post. That is one reason why colon cancer has become the second leading cause of cancer-related deaths among U.S. men and women combined. Colon cancer is highly treatable if caught early. But symptoms of colon cancer are often unnoticed or nonexistent until ... Read More

Study shows need for thorough polyp removal, continued surveillance

A new study by researchers from the University of Pittsburgh School of Medicine and Epidemiology confirms the need for continued colonoscopy surveillance in patients at risk for colorectal cancer, especially those with a history of precancerous polyps. It also highlights the importance for polyps, especially those that are precancerous, to be completely removed since cancer may develop at the site of polyp removal if residual tissue remains. The study focused on the rate of interval colorectal cancer in patients participating in the Polyp Prevention Trial Continued Follow-up Study, a four-year multicenter, randomized, controlled trial designed to examine the effects of ... Read More

Blood test to detect colon cancer seeks FDA approval

Yet another biotech company is diligently working to find a safer, less invasive test besides a colonoscopy to detect cancers of the colon and rectum. EDP Biotech Corporation of West Knoxville, Tenn., has announced that it is seeking FDA approval of a blood test to detect colon cancer at its earliest and most treatable stages. Colorectal cancer is the third most common cancer among men and women in the United States, and is among the most deadly of cancers. In an effort to improve those statistics, doctors began recommending that people have regular colon screenings, such as colonoscopies, to look ... Read More